Maxor Selected as Limited Distribution Provider of Orkambi® and Kalydeco®
Maxor National Pharmacy Services, LLC (“Maxor”), today announced that Vertex Pharmaceuticals Inc. has now included Maxor Specialty, comprised of IV Solutions and Pharmaceutical Specialties (“PSI”), in its specialty pharmacy network. Effectively immediately, patients may now utilize Maxor Specialty for Orkambi® and Kalydeco®, two leading medications used in the treatment of certain types of Cystic Fibrosis (“CF”).
“We are extremely proud and excited to begin providing Orkambi® and Kalydeco® to our Cystic Fibrosis patients. As a leader in the Cystic Fibrosis community, our focus has always been on providing complete and comprehensive care to our patients. CF patients often take more than 8 different medications a day, and access to the Vertex products now allows our pharmacists to help CF patients obtain and manage all of their prescribed medications through our specialty pharmacy,” said Mike Ellis, CEO of Maxor.
